Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 20, 2022

BUY
$224.46 - $253.15 $426,474 - $480,985
1,900 Added 126.67%
3,400 $766,000
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $346,065 - $385,110
1,500 New
1,500 $365,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ctc Capital Management, LLC Portfolio

Follow Ctc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ctc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ctc Capital Management, LLC with notifications on news.